chlorpropamide has been researched along with Hyperglycemia in 21 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of hyperglycemia on normal islets, rats were made diabetic by a 95% partial pancreatectomy and treated with insulin, saline, or chlorpropamide for 3 mo." | 7.66 | Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapy. ( Bown, E; Clark, A; King, T; Turner, RC; Vanhegan, RI, 1982) |
| "To investigate the effect of hyperglycemia on normal islets, rats were made diabetic by a 95% partial pancreatectomy and treated with insulin, saline, or chlorpropamide for 3 mo." | 3.66 | Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapy. ( Bown, E; Clark, A; King, T; Turner, RC; Vanhegan, RI, 1982) |
| " Recent evidence indicates that hyperglycemia in diabetic patients, but not in normal subjects, is characterized by elevations of circulating levels of arginine vasopressin (AVP; antidiuretic hormone, ADH)." | 3.66 | Water metabolism in diabetes mellitus. ( Davis, FB; Davis, PJ, 1981) |
| "Treatment with chlorpropamide (one to three months, average dose equals 375 mg/day) was associated with a marked reduction in hyperglycemia and an increase toward normal in insulin binding to mononuclear cells." | 1.26 | Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. ( Olefsky, JM; Reaven, GM, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yeung, JM | 1 |
| Knaus, EE | 1 |
| BRIGANTE, JC | 1 |
| LEVINE, R | 1 |
| SMITH, M | 1 |
| FOGLIA, VG | 1 |
| YABO, R | 1 |
| RODARI, T | 1 |
| MAGGI, G | 1 |
| SPECCHIA, G | 1 |
| Czyzyk, A | 1 |
| Ooms, HA | 1 |
| Wodon, C | 1 |
| Christophe, J | 1 |
| Clark, A | 1 |
| Bown, E | 1 |
| King, T | 1 |
| Vanhegan, RI | 1 |
| Turner, RC | 2 |
| Best, JD | 1 |
| Judzewitsch, RG | 1 |
| Pfeifer, MA | 1 |
| Beard, JC | 1 |
| Halter, JB | 1 |
| Porte, D | 1 |
| Kanefsky, TM | 1 |
| Medoff, SJ | 1 |
| Davis, FB | 1 |
| Davis, PJ | 1 |
| Olefsky, JM | 1 |
| Reaven, GM | 2 |
| Fajans, SS | 1 |
| Cloutier, MC | 1 |
| Crowther, RL | 1 |
| Richards, P | 1 |
| Pacuła, P | 1 |
| Janeczko, E | 1 |
| Trusiewicz, D | 1 |
| Koneczna, A | 1 |
| Tomaszczyk, M | 1 |
| Dembe, K | 1 |
| Stryjek-Kamińska, D | 1 |
| Hosker, JP | 1 |
| Burnett, MA | 1 |
| Davies, EG | 1 |
| Harris, EA | 1 |
| Felber, JP | 1 |
| Mehnert, H | 1 |
| Coppi, G | 1 |
| Bonardi, G | 1 |
| Ravid, M | 1 |
| Rubinstein, E | 1 |
| Cabili, S | 1 |
| Vorona, MI | 1 |
| Genes, SG | 1 |
| Grinchenko, TS | 1 |
| Kopelovich, MA | 1 |
| Lobanovskaia, LI | 1 |
1 review available for chlorpropamide and Hyperglycemia
| Article | Year |
|---|---|
Clinical and etiological heterogeneity of idiopathic diabetes mellitus. The banting memorial lecture.
Topics: Adenoma, Islet Cell; Adult; Antibodies, Viral; Autoantibodies; Cell Adhesion; Chlorpropamide; Chromo | 1979 |
20 other studies available for chlorpropamide and Hyperglycemia
| Article | Year |
|---|---|
Synthesis of N-(3,6-dihydro-1(2H)-pyridinyl)benzamides with hyperglycemic-hypoglycemic activity.
Topics: Animals; Benzamides; Blood Glucose; Hyperglycemia; Hypoglycemic Agents; Indicators and Reagents; Mag | 1987 |
[Chloropropamide in rats with endocrine insufficiencies and glucose tolerance].
Topics: Animals; Chlorpropamide; Glucose; Glucose Tolerance Test; Hyperglycemia; Hypophysectomy; Pancreas; R | 1963 |
ORAL HYPOGLYCEMIC AGENTS.
Topics: Chlorpropamide; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Phenformin | 1963 |
[ACTION OF CHLORPROPAMIDE ON NORMAL, PREDIABETIC AND DIABETIC RATS].
Topics: Animals; Carbohydrate Metabolism; Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Experimental | 1964 |
[Behavior of the double venous hyperglycemia test in diabetic subjects after prolonged treatment with chlorpropamide].
Topics: Chlorpropamide; Diabetes Mellitus; Hyperglycemia; Hypoglycemic Agents; Veins | 1961 |
[Hypoaminoacidemia in the dog after rapid intravenous injection of L-leucine].
Topics: Amino Acids; Animals; Biological Transport, Active; Blood Glucose; Chlorpropamide; Dogs; Glucose; Hy | 1967 |
Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapy.
Topics: Animals; Blood Glucose; Body Weight; Chlorpropamide; Dogs; Hyperglycemia; Insulin; Islets of Langerh | 1982 |
The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes.
Topics: Adult; Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Female; Glucose; Humans; Hyperglycemi | 1982 |
Stevens-Johnson syndrome and neutropenia with chlorpropamide therapy.
Topics: Aged; Agranulocytosis; Chlorpropamide; Female; Humans; Hyperglycemia; Neutropenia; Stevens-Johnson S | 1980 |
Water metabolism in diabetes mellitus.
Topics: Arginine Vasopressin; Chlorpropamide; Diabetes Insipidus; Diabetes Mellitus; Diabetic Nephropathies; | 1981 |
Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.
Topics: Adult; Chlorpropamide; Diabetes Mellitus; Female; Humans; Hyperglycemia; Insulin; Insulin Resistance | 1976 |
Drug-induced metabolic disease.
Topics: Anti-Inflammatory Agents; Antidepressive Agents; Chlorpropamide; Diabetes Mellitus; Diuretics; Gout; | 1979 |
[Evaluation of the late ineffectiveness of sulfonylurea derivatives in patients with diabetes mellitus hospitalized at the Gastroenterology and Metabolic Disease Clinic, Medical Academy, in Warsaw 1976-1987].
Topics: Adult; Age Factors; Aged; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Resistance; Drug Therapy, | 1989 |
Beneficial effect of moderate weight loss in older patients with non-insulin-dependent diabetes mellitus poorly controlled with insulin.
Topics: Aged; Body Weight; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Female | 1985 |
Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 2; Glucose; Glyburide; Human | 1985 |
Clinical use of radioimmunological plasma insulin assessment.
Topics: Adenoma, Islet Cell; Adult; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Diet; Glucose Toleranc | 1973 |
[Letter: Posthypoglycemic hyperglycemia].
Topics: Carbutamide; Chlorpropamide; Diabetes Mellitus; Humans; Hyperglycemia; Hypoglycemia; Insulin; Tolbut | 1974 |
[Action of tolbutamide, chlorpropamide and insulin on hyperglycemia induced by non-thiazide diuretics in rats].
Topics: Animals; Chlorpropamide; Chlorthalidone; Diuretics; Ethacrynic Acid; Female; Furosemide; Hyperglycem | 1969 |
Anaphylactic reaction to chlorpropamide.
Topics: Anaphylaxis; Antibodies; Blood Glucose; Chlorpropamide; Diabetes Mellitus; Humans; Hyperglycemia; Im | 1971 |
[The therapeutic efficacy of saccharoreducing preparation chlorcyclamide].
Topics: Adult; Chlorpropamide; Diabetes Mellitus; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; | 1968 |